|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/16 | |
| A61K 9/20 | |||
| A61K 9/28 | |||
| A61K 9/50 | |||
| A61K 31/436 |
| (11) | Number of the document | 2976064 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14717202.7 |
| Date of filing the European patent application | 2014-03-19 | |
| (97) | Date of publication of the European application | 2016-01-27 |
| (45) | Date of publication and mention of the grant of the patent | 2017-04-19 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/IB2014/059965 |
| Date | 2014-03-19 |
| (87) | Number | WO 2014/147567 |
| Date | 2014-09-25 |
| (30) | Number | Date | Country code |
| 201361803300 P | 2013-03-19 | US |
| (72) |
DIEDERICH, Anke, CH
KUNZLER, Hans-Ulrich, CH
GRANER, Oliver, CH
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
| (54) | PHARMACEUTICAL COMPOSITIONS COMPRISING EVEROLIMUS |
| PHARMACEUTICAL COMPOSITIONS COMPRISING EVEROLIMUS |